It’s easy to be confidently wrong with statistics.
Ivermectin improves outcomes in a hospital setting… but only in developing nations.
There’s two confounding effects there! One, you have to be sick enough to be treated in hospital and two, living in a place with high levels of endemic parasite infections.
Ivermectin treats parasites. Parasites are helped by the steroids given for severe infections. Treating the parasite infections does -- demonstrably -- help outcomes, but not uniformly. It's not a prophylactic and it won't do much of anything in developed nations where less than 1% of the population has parasites.
I noticed just how bad these studies were when I took Tamiflu for the worst flu I had ever had. I went from crying in pain to "this feels like a mild sniffle" in less than 12 hours, the fastest I had ever experienced flu symptoms subsiding.
My doctor recommended against taking Tamiful because it was expensive (not really) and that studies showed that its effects were marginal, something like reducing the duration of symptoms by a mere 1/2 a day out of 2-3 weeks.
Reducing the duration... reducing the duration. You see, there's no objective method for measuring symptom severity, so during studies of new medications, they don't. They measure duration. But duration is very difficult to reduce, because of the way the learning process of the immune system works. There's a bunch of sequential processes that occur sequentially.
Tamiflu reduces symptom severity but not duration. So apparently it's "worthless", because it improves only outcomes that aren't measured.
Whether you're crying in pain or not is apparently not objective enough...